Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors
US12083101B2 · kind B2 · utility
0Cited by
0References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2021 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Oct 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof;
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.